Determination of pindolol in human plasma by high-performance liquid chromatography
- 1 August 1980
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 183 (2) , 255-259
- https://doi.org/10.1016/s0378-4347(00)81703-x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia.Published by Wiley ,1979
- The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levelsClinical and Experimental Pharmacology and Physiology, 1975
- Pharmacokinetics of pindolol in manEuropean Journal of Clinical Pharmacology, 1974
- Prolonged action of pindolol.BMJ, 1973
- THE USE OF PRINDOLOL (VISKEN) IN THE TREATMENT OF HYPERTENSIONThe Medical Journal of Australia, 1972
- A potent β-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indoleJournal of Pharmacy and Pharmacology, 1970
- A method for the fluorimetric determination of 4-(2-Hydroxy-3-isopropylaminopropoxy)-indole (LB 46), aβ-blocking agent, in plasma and urineCellular and Molecular Life Sciences, 1969